The point-of-care technology market size has grown strongly in recent years. It will grow from $43.21 billion in 2025 to $47.41 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to dependence on centralized laboratory testing, limited access to rapid diagnostics in remote areas, growing burden of infectious diseases, increasing hospital patient volumes, early adoption of basic point-of-care devices.
The point-of-care technology market size is expected to see strong growth in the next few years. It will grow to $67.94 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to advancement in microfluidics and pcr technologies, rising prevalence of chronic and lifestyle diseases, growth in homecare and decentralized healthcare models, increasing healthcare digitization, supportive regulatory frameworks for rapid diagnostics. Major trends in the forecast period include rising demand for rapid diagnostic testing at point of care, increasing adoption of home-based and remote testing solutions, growth in portable and handheld diagnostic devices, expansion of infectious disease and chronic disease testing, improved focus on ease of use and faster turnaround time.
The rising prevalence of chronic illnesses is expected to drive significant growth in the point-of-care (POC) technology market. Chronic illnesses long-lasting conditions requiring continuous care are increasingly common due to sedentary lifestyles, which contribute to risk factors such as heart disease and diabetes. Point-of-care technology addresses these challenges by enabling rapid, on-site diagnostic testing in clinics, homes, or remote care settings. By providing real-time results, these technologies reduce treatment delays, improve patient monitoring, and enhance overall healthcare convenience. For example, in June 2024, the UK’s National Health Service reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, an 18% increase from 3,065,825 cases in 2022, highlighting the rising burden of chronic conditions and the resulting need for efficient diagnostic solutions.
Key players in the POC technology market are focusing on AI-powered diagnostic platforms to enhance accuracy, speed, and accessibility in disease detection. These platforms combine artificial intelligence with portable diagnostic devices to deliver real-time testing for critical conditions such as cancer. For instance, in February 2025, Avitia Inc., a Canada-based point-of-care diagnostics company, launched an AI-powered platform for rapid, on-site cancer testing. By integrating machine learning algorithms, the system allows healthcare providers to perform accurate screening outside traditional laboratories, reducing turnaround times, enabling early detection, and expanding access to underserved or remote populations.
In July 2024, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, acquired the point-of-care platform from LumiraDx Group Limited for approximately $350 million. This acquisition allows Roche to expand its footprint in decentralized diagnostics by integrating a portable, user-friendly platform capable of immunochemistry and clinical chemistry testing, with future potential for molecular diagnostics. LumiraDx Group Limited, based in the UK, specializes in next-generation POC diagnostic technologies, making this partnership a strategic step toward accessible and efficient patient-centered care.
Major companies operating in the point-of-care technology market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Cepheid Inc., Radiometer Medical ApS, Nova Biomedical, Sekisui Diagnostics LLC, Abaxis Inc., BHR Biosynex, EKF Diagnostics Holdings plc, Acon Laboratories Inc., Trinity Biotech plc, Chembio Diagnostics Inc., Arkray Inc., Orchard Software Corporation, Point of Care Biomedical Private Limited.
North America was the largest region in the point-of-care technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the point-of-care technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the point-of-care technology market by increasing costs of imported diagnostic components such as sensors, microfluidic chips, and electronic modules. Product segments including diagnostic and monitoring devices are most affected, particularly in Asia-Pacific and North America where global supply chains are deeply integrated. These cost pressures have slowed adoption in price-sensitive markets. However, tariffs have also encouraged local manufacturing, supply chain diversification, and innovation in cost-effective point-of-care solutions.
The point-of-care technology market research report is one of a series of new reports that provides point-of-care technology market statistics, including point-of-care technology industry global market size, regional shares, competitors with a point-of-care technology market share, detailed point-of-care technology market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care technology industry. This point-of-care technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Point-of-care technology refers to medical diagnostic devices and tools used at or near the site of patient care, including clinics, hospitals, or even homes. It provides rapid, accurate, and real-time diagnostic results, enabling timely clinical decisions and improving patient outcomes. This technology reduces reliance on centralized laboratory testing and accelerates the initiation of treatment.
The key types of point-of-care technology include diagnostic devices, monitoring devices, therapeutic devices, and data management systems. Diagnostic devices detect and identify diseases or health conditions by analyzing biological samples such as blood, saliva, or urine. These solutions are available under various models, including standalone, integrated, and cloud-based systems, and employ technologies such as microfluidics, polymerase chain reaction (PCR), and immunoassays. They are applied in areas including infectious disease testing, glucose monitoring, cardiometabolic monitoring, pregnancy and fertility testing, and more, serving end users such as hospitals, clinics, homecare settings, and ambulatory surgical centers.
The point-of-care technology market consists of revenues earned by entities by providing services such as rapid diagnostic testing, decentralized patient monitoring, emergency response diagnostics, and personalized treatment support. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care technology market also includes sales of handheld diagnostic devices, portable analyzers, lab-on-a-chip systems, digital test kits, and connected biosensors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The point-of-care technology market size is expected to see strong growth in the next few years. It will grow to $67.94 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to advancement in microfluidics and pcr technologies, rising prevalence of chronic and lifestyle diseases, growth in homecare and decentralized healthcare models, increasing healthcare digitization, supportive regulatory frameworks for rapid diagnostics. Major trends in the forecast period include rising demand for rapid diagnostic testing at point of care, increasing adoption of home-based and remote testing solutions, growth in portable and handheld diagnostic devices, expansion of infectious disease and chronic disease testing, improved focus on ease of use and faster turnaround time.
The rising prevalence of chronic illnesses is expected to drive significant growth in the point-of-care (POC) technology market. Chronic illnesses long-lasting conditions requiring continuous care are increasingly common due to sedentary lifestyles, which contribute to risk factors such as heart disease and diabetes. Point-of-care technology addresses these challenges by enabling rapid, on-site diagnostic testing in clinics, homes, or remote care settings. By providing real-time results, these technologies reduce treatment delays, improve patient monitoring, and enhance overall healthcare convenience. For example, in June 2024, the UK’s National Health Service reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, an 18% increase from 3,065,825 cases in 2022, highlighting the rising burden of chronic conditions and the resulting need for efficient diagnostic solutions.
Key players in the POC technology market are focusing on AI-powered diagnostic platforms to enhance accuracy, speed, and accessibility in disease detection. These platforms combine artificial intelligence with portable diagnostic devices to deliver real-time testing for critical conditions such as cancer. For instance, in February 2025, Avitia Inc., a Canada-based point-of-care diagnostics company, launched an AI-powered platform for rapid, on-site cancer testing. By integrating machine learning algorithms, the system allows healthcare providers to perform accurate screening outside traditional laboratories, reducing turnaround times, enabling early detection, and expanding access to underserved or remote populations.
In July 2024, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, acquired the point-of-care platform from LumiraDx Group Limited for approximately $350 million. This acquisition allows Roche to expand its footprint in decentralized diagnostics by integrating a portable, user-friendly platform capable of immunochemistry and clinical chemistry testing, with future potential for molecular diagnostics. LumiraDx Group Limited, based in the UK, specializes in next-generation POC diagnostic technologies, making this partnership a strategic step toward accessible and efficient patient-centered care.
Major companies operating in the point-of-care technology market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Cepheid Inc., Radiometer Medical ApS, Nova Biomedical, Sekisui Diagnostics LLC, Abaxis Inc., BHR Biosynex, EKF Diagnostics Holdings plc, Acon Laboratories Inc., Trinity Biotech plc, Chembio Diagnostics Inc., Arkray Inc., Orchard Software Corporation, Point of Care Biomedical Private Limited.
North America was the largest region in the point-of-care technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the point-of-care technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the point-of-care technology market by increasing costs of imported diagnostic components such as sensors, microfluidic chips, and electronic modules. Product segments including diagnostic and monitoring devices are most affected, particularly in Asia-Pacific and North America where global supply chains are deeply integrated. These cost pressures have slowed adoption in price-sensitive markets. However, tariffs have also encouraged local manufacturing, supply chain diversification, and innovation in cost-effective point-of-care solutions.
The point-of-care technology market research report is one of a series of new reports that provides point-of-care technology market statistics, including point-of-care technology industry global market size, regional shares, competitors with a point-of-care technology market share, detailed point-of-care technology market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care technology industry. This point-of-care technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Point-of-care technology refers to medical diagnostic devices and tools used at or near the site of patient care, including clinics, hospitals, or even homes. It provides rapid, accurate, and real-time diagnostic results, enabling timely clinical decisions and improving patient outcomes. This technology reduces reliance on centralized laboratory testing and accelerates the initiation of treatment.
The key types of point-of-care technology include diagnostic devices, monitoring devices, therapeutic devices, and data management systems. Diagnostic devices detect and identify diseases or health conditions by analyzing biological samples such as blood, saliva, or urine. These solutions are available under various models, including standalone, integrated, and cloud-based systems, and employ technologies such as microfluidics, polymerase chain reaction (PCR), and immunoassays. They are applied in areas including infectious disease testing, glucose monitoring, cardiometabolic monitoring, pregnancy and fertility testing, and more, serving end users such as hospitals, clinics, homecare settings, and ambulatory surgical centers.
The point-of-care technology market consists of revenues earned by entities by providing services such as rapid diagnostic testing, decentralized patient monitoring, emergency response diagnostics, and personalized treatment support. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care technology market also includes sales of handheld diagnostic devices, portable analyzers, lab-on-a-chip systems, digital test kits, and connected biosensors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Point-of-Care Technology Market Characteristics
3. Point-of-Care Technology Market Supply Chain Analysis
4. Global Point-of-Care Technology Market Trends and Strategies
5. Point-of-Care Technology Market Analysis of End Use Industries
7. Global Point-of-Care Technology Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Point-of-Care Technology Total Addressable Market (TAM) Analysis for the Market
9. Point-of-Care Technology Market Segmentation
10. Point-of-Care Technology Market Regional and Country Analysis
11. Asia-Pacific Point-of-Care Technology Market
12. China Point-of-Care Technology Market
13. India Point-of-Care Technology Market
14. Japan Point-of-Care Technology Market
15. Australia Point-of-Care Technology Market
16. Indonesia Point-of-Care Technology Market
17. South Korea Point-of-Care Technology Market
18. Taiwan Point-of-Care Technology Market
19. South East Asia Point-of-Care Technology Market
20. Western Europe Point-of-Care Technology Market
21. UK Point-of-Care Technology Market
22. Germany Point-of-Care Technology Market
23. France Point-of-Care Technology Market
24. Italy Point-of-Care Technology Market
25. Spain Point-of-Care Technology Market
26. Eastern Europe Point-of-Care Technology Market
27. Russia Point-of-Care Technology Market
28. North America Point-of-Care Technology Market
29. USA Point-of-Care Technology Market
30. Canada Point-of-Care Technology Market
31. South America Point-of-Care Technology Market
32. Brazil Point-of-Care Technology Market
33. Middle East Point-of-Care Technology Market
34. Africa Point-of-Care Technology Market
36. Point-of-Care Technology Market Competitive Landscape and Company Profiles
37. Point-of-Care Technology Market Other Major and Innovative Companies
40. Point-of-Care Technology Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Point-of-Care Technology Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses point-of-care technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for point-of-care technology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point-of-care technology market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Diagnostics Devices; Monitoring Devices; Therapeutic Devices; Data Management Systems2) By Ownership Model: Standalone Solutions; Integrated Solutions; Cloud-Based Solutions
3) By Technology: Microfluidics; Polymerase Chain Reaction (PCR); Immunoassays
4) By Application: Infectious Disease Testing; Glucose Monitoring; Cardiometabolic Monitoring; Pregnancy And Fertility Testing; Other Applications
5) By End-User: Hospitals; Clinics; Homecare Settings; Ambulatory Surgical Centers
Subsegments:
1) By Diagnostics Devices: Blood Glucose Monitoring Devices; Infectious Disease Testing Devices; Cardiac Marker Testing Devices; Coagulation Testing Devices; Pregnancy And Fertility Testing Devices; Urinalysis Testing Devices; Hematology Testing Devices; Cholesterol Testing Devices2) By Monitoring Devices: Vital Signs Monitoring Devices; Continuous Glucose Monitoring Devices; Cardiac Monitoring Devices; Respiratory Monitoring Devices
3) By Therapeutic Devices: Insulin Delivery Devices; Nebulizers; Dialysis Machines; Infusion Pumps
4) By Data Management Systems: Point Of Care (POC) Data Integration Systems; Point Of Care (POC) Middleware Solutions; Point Of Care (POC) Data Analytics Platforms
Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Hologic Inc.; bioMérieux SA; Quidel Corporation; Sysmex Corporation; Cepheid Inc.; Radiometer Medical ApS; Nova Biomedical; Sekisui Diagnostics LLC; Abaxis Inc.; BHR Biosynex; EKF Diagnostics Holdings plc; Acon Laboratories Inc.; Trinity Biotech plc; Chembio Diagnostics Inc.; Arkray Inc.; Orchard Software Corporation; Point of Care Biomedical Private Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Point-of-Care Technology market report include:- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Danaher Corporation
- Siemens Healthineers AG
- Hologic Inc.
- bioMérieux SA
- Quidel Corporation
- Sysmex Corporation
- Cepheid Inc.
- Radiometer Medical ApS
- Nova Biomedical
- Sekisui Diagnostics LLC
- Abaxis Inc.
- BHR Biosynex
- EKF Diagnostics Holdings plc
- Acon Laboratories Inc.
- Trinity Biotech plc
- Chembio Diagnostics Inc.
- Arkray Inc.
- Orchard Software Corporation
- Point of Care Biomedical Private Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 47.41 Billion |
| Forecasted Market Value ( USD | $ 67.94 Billion |
| Compound Annual Growth Rate | 9.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
